Creoptix

Creoptix develops next generation instruments for the high-sensitivity analysis of label-free molecular interactions.

Creoptix AG is a privately-held company focused on the development of next generation instruments for the high-sensitivity analysis of label-free molecular interactions based on a innovative, proprietary technology called Grating-Coupled Interferometry (GCI). Creoptix’ instruments are characterized by very high sensitivity while still being robust and customer-friendly. The main applications for its instruments are in the drug discovery industry and for life-science and materials research. Creoptix was founded in 2009.